Consistently, silencing of Jagged1 in OXA- or 5-FU–resistant colorectal cancer subpopulations restores their sensitivity to chemotherapy, confirming that drug response is Jag1-ICD–dependent [22]. The gene discussed is JAG1; the disease is colorectal cancer.